Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
Clinical trial NCT02065791 · COMPLETED
Trial details
- NCT number
- NCT02065791
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-17
- Primary completion
- 2018-10-30
- Enrollment
- 4401
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.